CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 1,560 enrolled
Drug / intervention
Anesthetic "depth" managementdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03330236
NCT03330236N/ACompleted
CompareCT.gov

Effect of Spectral Edge Frequency and Patient State Index (Electroencephalography) - Guided Anesthetic Care on Delirium After Laparoscopic Surgery: the EMODIPOD Randomized Controlled Trial

Yale University·interventional·Posted Nov 6, 2017·Updated Nov 9, 2020

In Brief

A clinical study evaluating Anesthetic "depth" management for Delirium and 5 related conditions. Completed, enrolled 1,560 participants across 1 site.

Detailed Summary

The study is a prospective, double blinded, randomized and controlled parallel trial to investigate the effect of the anesthetic care guided by EEG monitor (SedLine) on postoperative delirium. EMODIPOD = Electroencephalography Monitoring tO Decrease the Incidence of PostOperative Delirium

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDelirium, Emergence Delirium, Anesthesia, General, Electroencephalography, Laparoscopy, Surgical Procedures, Operative
CountriesChina
Collaborators--

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedNov 6, 2017
Enrollment StartOct 13, 2017
Primary CompletionSep 5, 2019
Study CompletionSep 6, 2019
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 8.7 years ago

Interventions

Anesthetic "depth" managementdevice

The propofol and remifentanil infusion rates will be adjusted to maintain the spectral edge frequency (SEF) value at 10-15 and the patient state index (PSI) value at 25-50 based on the SedLine EEG Brain Function Monitoring.